Biliary tract infections treated with ciprofloxacin

Infection ◽  
1993 ◽  
Vol 21 (4) ◽  
pp. 262-264 ◽  
Author(s):  
G. N. Karachalios ◽  
G. Zografos ◽  
V. Patrikakos ◽  
D. Nassopoulou ◽  
K. Kehagioglou
Gut Pathogens ◽  
2021 ◽  
Vol 13 (1) ◽  
Author(s):  
Mahoko Ikeda ◽  
Tatsuya Kobayashi ◽  
Fumie Fujimoto ◽  
Yuta Okada ◽  
Yoshimi Higurashi ◽  
...  

Abstract Background Although Escherichia coli is the most frequently isolated microorganism in acute biliary tract infections with bacteremia, data regarding its virulence are limited. Results Information on cases of bacteremia in acute biliary tract infection in a retrospective study was collected from 2013 to 2015 at a tertiary care hospital in Japan. Factors related to the severity of infection were investigated, including patient background, phylogenetic typing, and virulence factors of E. coli, such as adhesion, invasion, toxins, and iron acquisition. In total, 72 E. coli strains were identified in 71 cases, most of which primarily belonged to the B2 phylogroup (68.1%). The presence of the iutA gene (77.3% in the non-severe group, 46.4% in the severe group, P = 0.011) and the ibeA gene (9.1% in the non-severe group, and 35.7% in the severe group, P = 0.012) was significantly associated with the severity of infection. Among the patient characteristics, diabetes mellitus with organ involvement and alkaline phosphatase were different in the severe and non-severe groups. Conclusions We showed that bacteremic E. coli strains from acute biliary tract infections belonged to the virulent (B2) phylogroup. The prevalence of the iutA and ibeA genes between the two groups of bacteremia severity was significantly different.


1996 ◽  
Vol 34 (7) ◽  
pp. 1866-1867 ◽  
Author(s):  
D Pierard ◽  
B De Waele ◽  
L Covens ◽  
A Van Zeebroeck ◽  
P Rosseel ◽  
...  

1982 ◽  
Vol 4 (Supplement_3) ◽  
pp. S688-S691 ◽  
Author(s):  
O. Mueller ◽  
K. Fabricius ◽  
E. Krueger ◽  
U. Rueckert

1988 ◽  
Vol 32 (8) ◽  
pp. 1231-1236 ◽  
Author(s):  
M G Bergeron ◽  
J Mendelson ◽  
G K Harding ◽  
L Mandell ◽  
I W Fong ◽  
...  

Drugs ◽  
1999 ◽  
Vol 57 (1) ◽  
pp. 81-91 ◽  
Author(s):  
Jean-Fr??d??ric Westphal ◽  
Jean-Marie Brogard

Author(s):  
J. Frankard ◽  
H. Rodriguez-Villalobos ◽  
M. J. Struelens ◽  
F. Jacobs

Medicine ◽  
2014 ◽  
Vol 93 (18) ◽  
pp. e105 ◽  
Author(s):  
Caroline Charlier ◽  
Cindy Fevre ◽  
Laetitia Travier ◽  
Benoît Cazenave ◽  
Hélène Bracq-Dieye ◽  
...  

1990 ◽  
Vol 26 (suppl B) ◽  
pp. 167-172 ◽  
Author(s):  
J. P. Chacon ◽  
P. D. Criscuolo ◽  
C. M. Kobata ◽  
J. R. Ferraro ◽  
S. S. Saad ◽  
...  

2015 ◽  
Vol 18 (1) ◽  
pp. 34-38
Author(s):  
Cristian Balahura ◽  
◽  
Petre Iacob Calistru ◽  
Gabriel Constantinescu ◽  
◽  
...  

Introduction. The management of biliary tract infections involves systemic antibiotherapy and a biliary drainage procedure. Current guidelines provide recommendations for empirical antimicrobial therapy in cholangitis but development of multi-drug resistant organisms can make many of these antibiotics ineffective. This study aimed to analyze the microbiology of bile and the susceptibility profiles of organisms identified in patients with extrahepatic cholestatis, with or without a previously placed biliary stent. Materials and methods. We conducted a prospective study including 136 patients with biliary obstruction who were endoscopically drained between June 2014 and March 2015 in Emergency Hospital “Floreasca”, Bucharest. One hundred and four of these patients had no biliary stent in situ (group 1). Thirty-two procedures were performed in patients with at least one biliary stent in place (group 2). Microbiological examination of bile aspirates was performed and antibiotic susceptibilities were determined for the isolated bacteria. Results. One hundred eighteen of 136 analyzed cultures were positive (81% in group 1 vs. 100% in group 2; p<0.05). In both groups, the most frequent pathogens were Escherichia coli, Klebsiella spp. and Proteus spp. The most effective antimicrobial agents against Gram-negative bacteria in group 1 and group 2 were imipenem, cefoperazone/sulbactam and piperacillin/tazobactam. Susceptibilities to ceftazidime, cefotaxime, cefepime and fluoroquinolones were significantly lower in group 2. Conclusion. This survey shows that Gram-negative bacteria are the predominant bile pathogens found in patients with cholestatis. Cefoperazone/sulbactam, piperacillin/tazobactam or imipenem can be recommended in biliary infections. Cephalosporins and fluroquinolones should not be used as empirical therapy if a biliary stent is in place.


Sign in / Sign up

Export Citation Format

Share Document